Pulmonology Medical News about pneumonia

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
HIPAA Breaches Must Be Reported Soon

Dorothy J. Schirf, MD

Technology Advances

Nanotech Effort with Glioblastoma - Impressive or Impractical?

Sara Hartley

Cancer Science

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pneumocystis pneumonia in children
Paediatric Respiratory Reviews, 11/02/09

Pyrgos V et al. – Trimethoprim–sulphamethoxazole is used for initial therapy in most patients, while pentamidine, atovaquone, clindamycin plus primaquine, and dapsone plus trimethoprim are alternatives. Prophylaxis of high–risk patients reduces but does not eliminate the risk of PCP. Improved understanding of the pathogenesis of PCP is important for future advances against this life–threatening infection.

<< Previous
Chylothorax: Diagnosis and Management in Children

Next >>
Periostitis Secondary to Prolonged Voriconazole Therapy in Lung...